New VIA Disc NP trial points to a minimally invasive option for disc pain

A new sham-controlled trial of VIA Disc NP found that many people with chronic discogenic low back pain had meaningful pain and function improvements at 6 months after a minimally invasive intradiscal procedure. The results matter for patients who have tried conservative care but want to delay or avoid major spine surgery.

What did the new VIA Disc NP study actually show about chronic disc pain?

A new analysis from the ASCEND trial, reported through a recent GlobeNewswire release and published in the Journal of Clinical Medicine, looked at VIA Disc NP for people with chronic discogenic low back pain. These are patients whose pain is thought to come primarily from degeneration and irritation within the lumbar discs, rather than from a large disc herniation pressing on a nerve or clear spinal instability. Many had already tried more typical conservative care without lasting relief. The procedure involves placing a specialized allograft, derived from donated tissue, directly into the disc space through a needle in an outpatient setting under light sedation.

The trial used a sham-controlled design, which means that one group received the actual intradiscal product and another group went through a similar process without the active material. This type of design is considered more rigorous than simple before-and-after comparisons, because it helps separate true treatment effects from placebo response and natural fluctuations in pain. At 6 months, about 60 percent of those who received VIA Disc NP reached at least a 30 percent reduction in back pain, while only a very small fraction of the sham group met that same threshold before crossover. Disability scores, using the Oswestry Disability Index, improved more in the treatment group as well, suggesting that participants did not just feel better but also moved and functioned more easily in daily life.

It is important to remember that these results apply to a specific group of participants meeting strict study criteria. The people enrolled had imaging and symptoms that pointed to discogenic sources of pain and were not immediately headed for fusion or other major surgeries. The outcomes therefore do not mean VIA Disc NP would help every person with low back discomfort, sciatica, or spinal arthritis. However, for those who fit a similar profile as the study population, the numbers are encouraging and add to the growing menu of minimally invasive options between basic conservative care and more invasive surgery.

• VIA Disc NP is designed for carefully selected patients with chronic discogenic low back pain.
• The ASCEND trial compared VIA Disc NP against a sham procedure to test true effect.
• Around 60 percent of treated participants reached at least a 30 percent drop in pain at 6 months.
• Functional disability scores improved more in the treatment group than in the sham group.

How minimally invasive is VIA Disc NP and what happened with side effects?

One of the key reasons VIA Disc NP is attracting attention is the way it is delivered. Rather than a large incision or removal of bone, the procedure is performed percutaneously, meaning through the skin with a needle or small cannula. Patients in the trial were treated in an outpatient setting under light sedation, which is similar to the level of sedation used for many injection-based spine procedures. The goal is to restore or supplement disc tissue in a way that potentially supports the internal environment of the disc, rather than simply numbing nerves around it.

Safety findings from the ASCEND trial were reassuring in the short term. Reported serious adverse events linked directly to the product or procedure were rare, described as roughly a quarter of one percent. The investigators noted no cases of disc infection, no new neurologic injury, and no urgent conversion to open surgery because of the intradiscal treatment. That does not mean the procedure is risk free. Any time a needle enters the disc, there is some chance of infection, bleeding, or worsening symptoms, but this study suggests that with careful technique and patient selection, those risks may be relatively low.

The study also reported that patients who received VIA Disc NP went on to use fewer epidural steroid injections and less additional physical therapy over the following year when compared with those who remained on conservative care alone. That does not mean people stopped moving or exercising, but rather that reliance on repeated interventional pain procedures and extensive therapy sessions appeared to drop. For a busy Las Vegas resident juggling work on the Strip, family commitments, and desert activities, fewer repeat procedures and office visits can translate into less disruption, travel, and time away from what matters most, assuming similar benefits hold in regular clinical practice.

• The procedure is done percutaneously using a needle-based approach under light sedation.
• Participants were treated in an outpatient setting rather than a hospital stay.
• Serious product-related complications in the trial were reported as uncommon.
• No infections or unplanned surgeries were reported in the ASCEND study population.

Who might be a candidate for intradiscal treatments like VIA Disc NP?

The participants in the ASCEND trial represented a specific slice of the chronic low back pain population. They had long-standing lumbar pain that had not responded adequately to standard non-surgical care, such as physical therapy, activity modification, and medications. Their imaging studies suggested that worn or degenerating discs were a primary pain source rather than major spinal instability, large nerve-compressing disc herniations, or fractures. They also were screened to exclude certain conditions that might make intradiscal intervention less appropriate or more risky. In other words, there was careful gatekeeping before anyone was enrolled and treated.

For people outside a controlled trial, candidacy for VIA Disc NP or any intradiscal therapy starts with a thoughtful evaluation. That typically includes a detailed discussion of symptoms, a review of medical history, physical examination, and imaging. A clinician will consider how long the pain has been present, what has already been tried, and whether patterns on MRI or other scans line up with disc-related pain rather than other issues like severe spinal stenosis or significant joint arthritis. Individuals also need to weigh their overall health, comfort with minimally invasive procedures, and willingness to continue ongoing conservative care, such as targeted exercise and posture work, after the injection.

Residents of the Las Vegas Valley face their own set of factors, from long shifts in hospitality or construction to prolonged driving across the city. All of these can load the lower back in different ways. A treatment that might be helpful for one worker who stands at a casino table most of the day may not be ideal for another who spends long hours seated at a computer or driving between properties. That is why a local spine or pain specialist will look at the full picture, not just an MRI report. Intradiscal options like VIA Disc NP are one piece of a larger toolbox and are not a universal fix.

How does VIA Disc NP fit alongside non-drug, non-surgical spine care?

Around the same time that the VIA Disc NP results were shared, a large systematic review in PLOS Medicine examined non-pharmacologic, non-surgical options for low back pain. This review, reported by MedicalXpress, pooled nearly 20 individual studies and close to 14,900 participants. It found that approaches such as yoga, structured exercise, acupuncture, massage, cognitive behavioral strategies, spinal manipulation, mindfulness, and some diet plus activity programs were not only clinically helpful for many people, but also cost effective compared with usual care or no treatment. That kind of evidence reinforces the value of self-management and guided movement even as newer interventional options arrive.

From a practical standpoint, this means that a minimally invasive intradiscal procedure is unlikely to replace foundational care. For many patients, the path to better back health blends several elements over time. Early on, this often includes education, graded activity, posture coaching, and targeted exercises to support the spine. Later, if pain remains stubborn and imaging points toward specific disc problems, a patient might explore additional options such as injections, nerve procedures, or intradiscal therapies in partnership with their provider. Even then, maintaining strength, flexibility, and good ergonomics usually plays a key role in how well someone does over the long term.

For people in Las Vegas, where work often involves repetitive lifting, prolonged standing, or gaming and hospitality tasks, combining evidence-based movement approaches with any procedure can be especially important. For example, someone who responds well to a minimally invasive disc treatment still needs strategies to manage long shifts, hotel corridor walking, or hours at a resort desk. The good news from the PLOS Medicine review is that many non-drug therapies offer solid value, which matters for both out-of-pocket costs and quality of life. The evolving role of VIA Disc NP can be seen as complementing, not replacing, these established approaches.

• A major review found yoga, exercise, and other non-drug therapies often improve low back pain.
• Many of these approaches were also more cost effective than usual care or no treatment.
• Conservative care typically remains the first-line approach before considering intradiscal options.
• Combining ongoing movement and posture strategies with any procedure often supports longer term comfort.

What should Las Vegas patients ask before considering VIA Disc NP or similar procedures?

If you are living with chronic low back pain in Las Vegas and have heard about VIA Disc NP, it is reasonable to bring it up in a visit with a qualified spine or pain specialist. Before focusing on any single procedure, your provider will want to make sure your pain pattern, exam findings, and imaging line up with discogenic pain similar to that studied in the ASCEND trial. You can ask directly whether your discs appear to be the likely source of pain, or whether joints, muscles, nerves, or other structures may be more important contributors. Clarifying this early can help avoid chasing treatments that are less likely to address the real problem.

It also makes sense to ask about the full range of non-surgical options that fit your situation, not just VIA Disc NP. Questions might include which conservative therapies you have not yet tried, how long to give each approach, and how different procedures compare in terms of recovery time, risks, and strength of evidence. Because VIA Disc NP is a relatively new intervention, you may want to understand how much real-world experience your provider has with it, whether you fit the typical candidate profile from the trial, and what kind of follow-up plan they recommend after the procedure. Expect an honest discussion about uncertainty as well as potential benefits.

No single article can substitute for individualized advice. Results with any treatment, from exercise to intradiscal injections, vary from person to person. If you are ready to explore non-surgical options more deeply, a consult at a spine-focused clinic in the valley, such as Las Vegas Spine & Disc, can give you space to review your imaging, walk through your daily demands, and map out a realistic stepwise plan. The priority is always to match the right level of care to your goals, risk tolerance, and overall health, rather than simply chasing the newest technique.

1. Ask your spine or pain specialist whether your MRI and symptoms suggest discogenic pain similar to the patients studied with VIA Disc NP, or whether another source is more likely.
2. Review which conservative treatments you have already tried, such as structured exercise, physical therapy, or cognitive behavioral strategies, and discuss whether any deserve a more focused trial before considering intradiscal procedures.
3. If your clinician mentions VIA Disc NP, request a clear explanation of how the procedure works, what happens on the day of treatment, and how long you might need to modify your activity afterward.
4. Compare VIA Disc NP with other minimally invasive options your provider recommends, asking about comparative risks, strength of evidence, and how each might fit your lifestyle and work demands in Las Vegas.
5. Plan a spine-friendly daily routine that supports any procedure you might have, including regular movement breaks, core and hip strengthening exercises, and attention to sitting and lifting posture.
6. Talk with your provider about cost considerations, including whether your insurance recognizes this newer treatment and what your likely out-of-pocket expenses could be compared with ongoing injections or therapy.
7. Keep a brief pain and activity journal for a few weeks before your consultation so you can give your clinician precise details about what worsens or eases your back symptoms.
8. If you are not ready for a procedure, explore evidence-supported non-drug options like yoga, mindfulness-based programs, and graded exercise that you can start now under professional guidance.
9. Revisit your workstation, driving posture, and home setup, making small ergonomic changes that reduce strain on your lower back while you and your provider decide on the best treatment path.
10. Schedule periodic follow-ups to reassess your progress, whether you choose VIA Disc NP, a different procedure, or conservative care alone, so your plan can be adjusted based on how you actually respond.

← More from the Las Vegas Spine & Disc blog